FDA NDC Directory · JSON-LD · Markdown

Roflumilast

NDC 67877-730 · HUMAN PRESCRIPTION DRUG · TABLET

Labeler / ManufacturerAscend Laboratories, LLC
Marketing categoryAbbreviated NDA (generic) · App ANDA212490
Dosage form / routeTABLET · ORAL
Active ingredientsROFLUMILAST (250 ug/1)
Marketing started20250314
Package count5

External sources

Source: openFDA. Public-domain (CC0).